| dc.contributor.author | Çırak, Selen | |
| dc.contributor.author | Tüzün, Erdem | |
| dc.contributor.author | Türkoğlu, Recai | |
| dc.contributor.author | Koral, Gizem | |
| dc.contributor.author | Yılmaz, Vuslat | |
| dc.contributor.author | Sağır, Fatma | |
| dc.contributor.author | Ersoy Tunalı, Nagehan | |
| dc.contributor.author | Tombul, Temel | |
| dc.date.accessioned | 2021-12-10T11:17:09Z | |
| dc.date.available | 2021-12-10T11:17:09Z | |
| dc.date.issued | 2021 | |
| dc.identifier.citation | Sağır F., Ersoy Tunalı N., Tombul T., Koral G., Çırak S., Yılmaz V., Türkoğlu R., Tüzün E., "miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study", Genetic Testing And Molecular Biomarkers, cilt.25, sa.11, ss.720-726, 2021 | |
| dc.identifier.issn | 1945-0265 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_73c0bd1e-03e0-45e7-b7f3-9e4d9751fcb9 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/171582 | |
| dc.identifier.uri | https://doi.org/10.1089/gtmb.2021.0183 | |
| dc.identifier.uri | https://www.liebertpub.com/doi/full/10.1089/gtmb.2021.0183 | |
| dc.language.iso | eng | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Klinik Tıp (MED) | |
| dc.title | miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study | |
| dc.type | Makale | |
| dc.relation.journal | Genetic Testing And Molecular Biomarkers | |
| dc.contributor.department | , , | |
| dc.identifier.volume | 25 | |
| dc.identifier.issue | 11 | |
| dc.identifier.startpage | 720 | |
| dc.identifier.endpage | 726 | |
| dc.contributor.firstauthorID | 2759771 | |
